Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | -18.25% | -19.08% | +35.67% |
05:37pm | Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
09/05 | Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.67% | 3.76B | |
-28.74% | 9.96B | |
-21.44% | 2.37B | |
-11.15% | 2.27B | |
-23.34% | 1.58B | |
+60.23% | 1.31B | |
-1.31% | 750M | |
+18.67% | 575M | |
-27.45% | 525M | |
+5.37% | 337M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Insider Bought Shares Worth $292,800, According to a Recent SEC Filing